After revamping R&D in a global shakeup, Bayer prepping new labs for an expansion in cancer research at MIT

At Bayer, Pittsburgh is out, Cambridge, MA is in.

As part of a global shakeup that is costing 12,000 jobs, Bayer recently announced that it will shut down its old US HQ in Pennsylvania, axing hundreds of staffers. And that is happening while R&D is taking a big hit at the German multinational, with 900 researchers getting cut as Bayer completes the troublesome Monsanto acquisition.